← All Sponsors

SPONSOR

Sling Therapeutics, Inc.

Total Trials

1

Recruiting

1

Phases

Phase 2, Phase 3

Conditions studied: Thyroid Eye Disease Graves Orbitopathy Endocrine System Diseases Eye Diseases Thyroid Associated Ophthalmopathy Graves Ophthalmopathy Thyroid Diseases Orbital Diseases Proptosis IGF1R

NCT06112340 Phase 2, Phase 3

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)

Thyroid Eye Disease